Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
d-amphetamine and contingency management for cocaine use disorder
NCT02773212Phase 2Completed
- Sponsor
- University of Illinois Chicago
- Start
- Feb 2017
- Primary completion
- Apr 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of adenosine-5′-monophosphate in cocaine use disorder (CUD) (3 arms), sponsored by University of Illinois Chicago. Primary endpoint: Number of Participants Who Were Cocaine Abstinent at 4 weeks. Started Feb 2017; status: completed.
02
Drugs
adenosine-5′-monophosphate
03
Conditions
cocaine use disorder (CUD)
Beyond the preview
Go deeper on NCT02773212.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02773212.